NASDAQ NMS - GLOBAL MARKET · BDSX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Biodesix Inc

Biodesix Inc

Health Care
$26.63
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
BDSX
Biodesix Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BDSX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BDSX catalysts
About Biodesix Inc
SERVICES-MEDICAL LABORATORIES
Listed since
2020
Employees
334
Country
US

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$26.63
Last session
Day high
$26.63
Last session
Day low
$26.63
Last session
Previous close
$26.63
52W high
$26.63
0.00% from high
52W low
$5.46
100% of range
Market cap
$281M
EPS
$-2.7600
Beta
1.63
Shares out
10.6M
Avg volume
91K
VWAP
$26.63
Last session
Price history computed in-house
1W
+14.54%
1M
+21.05%
3M
+79.81%
1Y
+193.67%
YTD
+291.62%
SMA 50 $21.26 · above
SMA 200 $14.01 · above
52W position 100%

BDSX overview

Veridion Score
59
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BDSX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BDSX Form 4 filings
Public disclosures

Congress activity in BDSX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BDSX in the cached public ledger.

Federal contracts

BDSX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BDSX in this window.
Lobbying spend

BDSX lobbying filings, year to date.

Registered lobbying filings matched to Biodesix Inc.

$90.0K
Refresh interval: 12hSource: LDA disclosure filings
Medicare/Medicaid Health Issues
Filing
$30.0K
BIODESIX INC.

TODD STRATEGY GROUP

Jul 20, 2026
Filing
$30.0K
BIODESIX INC.

TODD STRATEGY GROUP

Apr 20, 2026
Filing
$30.0K
BIODESIX INC.

TODD STRATEGY GROUP

Jan 20, 2026
Loading news for BDSX
Analyst ratings
Sovereign unlock shows live analyst consensus for BDSX.
Options
Sovereign unlock shows live options positioning for BDSX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.